Alcon reports single-digit growth in second quarter

Alcon reported $2.6 billion in net sales and an underlying growth of 2% in the second quarter of 2015, according to a Novartis press release.“This was driven by lower sales in the U.S. and Asia, which resulted from a slowdown in our surgical equipment sales as well as softer IOL sales due to mix and pricing challenges despite strong continued unit growth, and an accelerated decline in our contact lens care solutions business,” Jeff George, Global Head of Alcon, said in a video presentation.